Skip to main content

Advertisement

Table 3 Study arms

From: A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron

Group Dose (mg/day Fe) Universal (N) Screen with Hepcidin (Yes or No)
A 60 154 No
Ba 60 154 Yes
Ca 30 154 Yes
  1. aGroups B and C will be tested weekly and only given their next seven day supply of iron if plasma hepcidin falls below cut-off for ‘safe and ready’